Back to Search

PAUL DORINSKY, MD

MD

Pulmonary Disease Physician

NPI: 1710050539Individual

Specialties, Licenses & Credentials

Pulmonary Disease PhysicianPrimary

Internal Medicine — Pulmonary Disease

Code: 207RP1001X

9900475(NC)

Research & Publications (20)

Use of changes in symptoms to predict changes in lung function in assessing the response to asthma therapy.
PMID 11394729·Clin Ther·2001
4-observational
Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down".
PMID 18951261·J Asthma·2008
2-rct
Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
PMID 18328683·Respir Med·2008
4-observational
Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
PMID 18206361·Respir Med·2008
4-observational
Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
PMID 17825690·Clin Ther·2007
4-observational
Safety of long-acting beta-agonists.
PMID 17088589·Ann Intern Med·2006
8-other
Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
PMID 17030231·J Allergy Clin Immunol·2006
2-rct
Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol.
PMID 16815137·J Allergy Clin Immunol·2006
2-rct
Variability in asthma severity in pediatric subjects with asthma previously receiving short-acting beta2-agonists.
PMID 16647416·J Pediatr·2006
8-other
Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
PMID 16490581·Clin Ther·2006
2-rct
The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol.
PMID 16424409·Chest·2006
4-observational
Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control.
PMID 16236835·Chest·2005
3-trial
Determining economic feasibility of fluticasone propionate-salmeterol vs montelukast in the treatment of persistent asthma using a net benefit approach and cost-effectiveness acceptability curves.
PMID 16136769·Ann Allergy Asthma Immunol·2005
3-trial
The safety of twice-daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistent asthma.
PMID 16095144·Ann Allergy Asthma Immunol·2005
3-trial
Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma.
PMID 15702819·Ann Allergy Asthma Immunol·2005
3-trial
Efficacy and safety of fluticasone propionate/salmeterol HFA 134A MDI in patients with mild-to-moderate persistent asthma.
PMID 15641629·J Asthma·2004
3-trial
Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
PMID 15609769·Ann Allergy Asthma Immunol·2004
4-observational
The relationship between health-related quality of life, lung function and daily symptoms in patients with persistent asthma.
PMID 15588035·Respir Med·2004
1-meta
Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
PMID 15521371·Ann Allergy Asthma Immunol·2004
3-trial
Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
PMID 15294013·Pharmacoeconomics·2004
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1200 OLD YORK RD
ABINGTON, PA 19001

Location

Practice Location

1200 OLD YORK RD, ABINGTON, PA
(215) 481-2180

Quick Facts

NPI
1710050539
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile